vs
Side-by-side financial comparison of AerSale Corp (ASLE) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $90.9M, roughly 1.9× AerSale Corp). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -4.0%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 0.2%).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
ASLE vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.9M | $168.4M |
| Net Profit | $5.4M | — |
| Gross Margin | 34.1% | — |
| Operating Margin | 7.8% | 50.6% |
| Net Margin | 5.9% | — |
| Revenue YoY | -4.0% | 143.7% |
| Net Profit YoY | 99.7% | — |
| EPS (diluted) | $0.10 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.9M | $168.4M | ||
| Q3 25 | $71.2M | $87.3M | ||
| Q2 25 | $107.4M | $82.4M | ||
| Q1 25 | $65.8M | $65.0M | ||
| Q4 24 | $94.7M | $69.1M | ||
| Q3 24 | $82.7M | $51.6M | ||
| Q2 24 | $77.1M | $73.8M | ||
| Q1 24 | $90.5M | $137.7M |
| Q4 25 | $5.4M | — | ||
| Q3 25 | $-120.0K | $-31.3M | ||
| Q2 25 | $8.6M | $-12.7M | ||
| Q1 25 | $-5.3M | $-40.5M | ||
| Q4 24 | $2.7M | — | ||
| Q3 24 | $509.0K | $-29.5M | ||
| Q2 24 | $-3.6M | $-61.9M | ||
| Q1 24 | $6.3M | $61.0M |
| Q4 25 | 34.1% | — | ||
| Q3 25 | 30.2% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 27.3% | — | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 31.8% | — |
| Q4 25 | 7.8% | 50.6% | ||
| Q3 25 | 4.0% | -11.4% | ||
| Q2 25 | 11.7% | 8.6% | ||
| Q1 25 | -10.1% | -34.0% | ||
| Q4 24 | 5.2% | -6.4% | ||
| Q3 24 | 2.4% | -31.0% | ||
| Q2 24 | -2.4% | 3.5% | ||
| Q1 24 | 5.2% | 52.5% |
| Q4 25 | 5.9% | — | ||
| Q3 25 | -0.2% | -35.9% | ||
| Q2 25 | 8.0% | -15.4% | ||
| Q1 25 | -8.0% | -62.2% | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 0.6% | -57.2% | ||
| Q2 24 | -4.7% | -83.9% | ||
| Q1 24 | 6.9% | 44.3% |
| Q4 25 | $0.10 | $0.32 | ||
| Q3 25 | $0.00 | $-0.16 | ||
| Q2 25 | $0.18 | $-0.06 | ||
| Q1 25 | $-0.10 | $-0.21 | ||
| Q4 24 | $0.05 | $-0.14 | ||
| Q3 24 | $0.01 | $-0.15 | ||
| Q2 24 | $-0.07 | $-0.33 | ||
| Q1 24 | $0.12 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $167.9M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $424.4M | $-302.0M |
| Total Assets | $640.5M | $465.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $167.9M | ||
| Q3 25 | $5.3M | $92.4M | ||
| Q2 25 | $5.7M | $86.1M | ||
| Q1 25 | $4.7M | $114.6M | ||
| Q4 24 | $4.7M | $144.8M | ||
| Q3 24 | $9.8M | $144.7M | ||
| Q2 24 | $4.3M | $189.3M | ||
| Q1 24 | $2.6M | $226.6M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $424.4M | $-302.0M | ||
| Q3 25 | $417.1M | $-451.4M | ||
| Q2 25 | $415.9M | $-433.5M | ||
| Q1 25 | $406.5M | $-426.2M | ||
| Q4 24 | $455.6M | $-388.7M | ||
| Q3 24 | $451.5M | $-370.2M | ||
| Q2 24 | $449.8M | $-344.2M | ||
| Q1 24 | $452.0M | $-294.3M |
| Q4 25 | $640.5M | $465.9M | ||
| Q3 25 | $646.3M | $364.0M | ||
| Q2 25 | $646.7M | $347.1M | ||
| Q1 25 | $646.1M | $324.0M | ||
| Q4 24 | $604.7M | $343.8M | ||
| Q3 24 | $601.5M | $314.1M | ||
| Q2 24 | $598.7M | $352.3M | ||
| Q1 24 | $571.7M | $373.1M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $45.2M |
| Free Cash FlowOCF − Capex | $9.8M | — |
| FCF MarginFCF / Revenue | 10.8% | — |
| Capex IntensityCapex / Revenue | 1.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $45.2M | ||
| Q3 25 | $-8.9M | $-4.3M | ||
| Q2 25 | $19.8M | $-31.4M | ||
| Q1 25 | $-45.2M | $-22.6M | ||
| Q4 24 | $37.5M | $-35.0M | ||
| Q3 24 | $10.4M | $-35.3M | ||
| Q2 24 | $-15.3M | $-7.2M | ||
| Q1 24 | $-21.5M | $53.8M |
| Q4 25 | $9.8M | — | ||
| Q3 25 | $-9.8M | — | ||
| Q2 25 | $18.6M | — | ||
| Q1 25 | $-47.6M | — | ||
| Q4 24 | $32.3M | — | ||
| Q3 24 | $8.9M | $-35.5M | ||
| Q2 24 | $-18.9M | $-7.3M | ||
| Q1 24 | $-25.0M | $53.8M |
| Q4 25 | 10.8% | — | ||
| Q3 25 | -13.8% | — | ||
| Q2 25 | 17.3% | — | ||
| Q1 25 | -72.4% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 10.7% | -68.7% | ||
| Q2 24 | -24.6% | -9.9% | ||
| Q1 24 | -27.7% | 39.0% |
| Q4 25 | 1.7% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 3.7% | 0.0% | ||
| Q4 24 | 5.6% | 0.0% | ||
| Q3 24 | 1.9% | 0.3% | ||
| Q2 24 | 4.7% | 0.1% | ||
| Q1 24 | 3.9% | 0.1% |
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
